Hepatitis A Virus (HAV) Polyclonal Antibody
HAV polyclonal antibody is developed for hepatitis A assay research using complementary recombinant antigen resources. It is suitable as an immunoreagent for serological test development and optimization.
Product Parameters
| Parameter | Specification |
|---|---|
| Code | FBHA1 |
Product Overview
HAV polyclonal antibody is developed as an immunoreagent for hepatitis A assay research and serological test development. Its multi-epitope recognition profile can support assay screening and optimization where broader binding to HAV antigen is useful.
EXIMIO also supplies recombinant HAV antigen resources, allowing the antibody to be evaluated together with complementary antigen materials during assay design and reagent selection.
Key Features
- Polyclonal format for broad recognition of HAV antigenic epitopes.
- Designed for research, reagent screening and assay-development workflows.
- Can be evaluated with recombinant HAV antigen materials to establish suitable assay combinations.
Applications
- Hepatitis A serological assay development.
- ELISA and other immunoassay feasibility studies.
- Optimization of coating, detection or control reagent configurations according to the final assay design.